Neu-Ulm, Germany

Manfred Erdmann


 

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 1990-2020

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Manfred Erdmann: Innovator in Pharmaceutical Chemistry

Introduction

Manfred Erdmann is a notable inventor based in Neu-Ulm, Germany. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of three patents. His work focuses on innovative formulations and compositions that enhance the efficacy of pharmaceutical compounds.

Latest Patents

Erdmann's latest patents include the "Crystalline form and acetic acid adducts of palbociclib." This invention relates to an adduct of palbociclib, detailing a method of preparation and a pharmaceutical composition that includes this compound. More specifically, it provides a crystalline form of palbociclib, along with a method for its preparation and a pharmaceutical composition comprising the same. Another significant patent is the "Acid addition salt of ibrutinib," which pertains to acid addition salts of ibrutinib, a pharmaceutical composition that includes these salts, and a method for their preparation.

Career Highlights

Throughout his career, Manfred Erdmann has worked with prominent companies in the pharmaceutical industry, including Ratiopharm GmbH and Merckle GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation and delivery.

Collaborations

Erdmann has collaborated with several professionals in his field, including Wolfgang Albrecht and Jens Geier. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Manfred Erdmann's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the industry. His work continues to influence the development of effective pharmaceutical compositions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…